Dogwood Therapeutics, Inc.

General ticker "DWTX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $67.8M (TTM average)

Dogwood Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -28.7%.

Estimated limits based on current volatility of 5.8%: low 1.05$, high 1.18$

Factors to consider:

  • Total employees count: 8 (-33.3%) as of 2025
  • Company does not operate outside US (retrieved using AI)
  • Top business risk factors: Insufficient capital, Clinical trial failure, Regulatory and compliance, Commercialization challenges, Intellectual property risks
  • Current price 62.2% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [2.86$, 8.07$]
  • 2026-12-31 to 2027-12-31 estimated range: [2.14$, 6.35$]

Financial Metrics affecting the DWTX estimates:

  • Negative: with PPE of -0.2 at the end of fiscal year the price was high
  • Negative: negative Operating income
  • Negative: negative Operating cash flow
  • Negative: negative Industry operating cash flow (median)
  • Negative: Shareholder equity ratio, % of 83.06 > 81.82
  • Positive: Inventory ratio change, % of 0 <= 0
  • Negative: Investing cash flow per share per price, % of 0 <= 2.40
  • Negative: -0.26 < Industry inventory ratio change (median), % of 0
  • Negative: negative Net income

Similar symbols

Short-term DWTX quotes

Long-term DWTX plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $5.45MM $12.23MM $27.97MM
Operating Income $-5.45MM $-12.23MM $-27.97MM
Non-Operating Income $0.15MM $-0.12MM $-6.07MM
R&D Expense $1.73MM $3.53MM $21.87MM
Income(Loss) $-5.30MM $-12.35MM $-34.04MM
Taxes $0.00MM $-0.00MM $0.22MM
Net Income(Loss)* $-5.30MM $-12.35MM $-34.26MM
Stockholders Equity $3.81MM $-10.12MM $74.90MM
Assets $4.17MM $94.31MM $90.17MM
Operating Cash Flow $-4.87MM $-8.79MM $-15.62MM
Capital expenditure $0.00MM $0.00MM $0.00MM
Investing Cash Flow $0.00MM $3.76MM $0.00MM
Financing Cash Flow $1.16MM $16.70MM $7.28MM
Earnings Per Share** $-7.05 $-12.02 $-4.17

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.